Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schulte, Johannes" or (type any "bookEditor issueEditor" and editor="Schulte, Johannes")

Add to list
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19

Hetty Helsmoortel (UGent) , Barbara De Moerloose (UGent) , Tim Pieters (UGent) , Farzaneh Ghazavi (UGent) , Silvia Bresolin, Helene Cave, Andrica de Vries, Valerie de Haas, Christian Flotho, Veerle Labarque, et al.

(2016) HAEMATOLOGICA. 101(6). p.E240-E244
Add to list
- Conference Paper
- C3
The chromosome 17q super-enhancer landscape in neuroblastoma

Bieke Decaesteker (UGent) , Anton Henssen, Wouter Van Loocke (UGent) , Anneleen Beckers (UGent) , Stein Aerts, Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2015) Combined SIOPEN annual general meeting and 4th Neuroblastoma Research symposium, Abstracts. p.17-17
Add to list
- Conference Paper
- C3
Long non-coding RNAs as upstream regulators and downstream effectors of TP53 activity in neuroblastoma

Dries Rombaut, Steve Lefever (UGent) , Jan Koster, Johannes Schulte, Rogier Versteeg, Peter van Sluis, Jo Vandesompele (UGent) and Pieter Mestdagh (UGent)

(2015) OncoPoint, 3rd Meeting, Abstracts.
Add to list
- Conference Paper
- C3
The chromosome 17q super-enhancer landscape in neuroblastoma

Bieke Decaesteker (UGent) , Anton Henssen, Wouter Van Loocke, Anneleen Beckers (UGent) , Stein Aerts, Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2015) European Cancer Epigenetics conference, 1st, Abstracts. p.39-39
Add to list
- Conference Paper
- C3
The HBP1 tumour suppressor at multiple regulatory cross roads in neuroblastoma

Shana Claeys (UGent) , Irina Lambertz (UGent) , Alan Van Goethem (UGent) , Anneleen Beckers (UGent) , Candy Kumps (UGent) , Tom Van Maerken (UGent) , Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2015) New trends in anticancer drug development, CNIO Frontiers Meeting, Abstracts.
Add to list
- Conference Paper
- C3
Synergistic combined molecular treatment targeting the HBP1 tumor suppressor gene in neuroblastoma

Shana Claeys (UGent) , Irina Lambertz (UGent) , Alan Van Goethem (UGent) , Anneleen Beckers (UGent) , Candy Kumps (UGent) , Tom Van Maerken (UGent) , Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2015) OncoPoint, 3rd Meeting, Abstracts.
Add to list
- Conference Paper
- C3
lncRNAs as upstream regulators and downstream effectors of TP53 in neuroblastoma

Dries Rombaut, Steve Lefever (UGent) , Pieter-Jan Volders (UGent) , Jan Koster, Sven Lindner, Johannes Schulte, Alan Van Goethem (UGent) , Rogier Versteeg, Peter van Sluis, Jo Vandesompele (UGent) , et al.

(2015) Keystone symposia on Molecular and Cellular Biology, Abstracts.
Add to list
- Conference Paper
- C3
ETV5 functionally connect ALK and RET signaling in neuroblastoma

Irina Lambertz (UGent) , Shana Claeys (UGent) , Candy Kumps (UGent) , Liselot Mus (UGent) , Anneleen Beckers (UGent) , Els Janssens, Nadine Van Roy (UGent) , Genevieve Laureys (UGent) , Johannes Schulte, Olivier De Wever (UGent) , et al.

(2015) Combined SIOPEN annual general meeting and 4th Neuroblastoma Research symposium, Abstracts.
Add to list
- Conference Paper
- C3
HBP1 downregulation through mutant ALK represents a novel mechanism for cooperative MYCN activation in neuroblastoma

Shana Claeys (UGent) , Irina Lambertz (UGent) , Alan Van Goethem (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Annelies Fieuw (UGent) , Tom Van Maerken (UGent) , Kristina Althoff, Johannes Schulte, Jean-Baptiste Demoulin, et al.

(2015) Combined SIOPEN annual general meeting and 4th Neuroblastoma Research symposium, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) New trends in anticancer drug development, CNIO Frontiers Meeting, Abstracts.

← Previous

Academic Bibliography

LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19

The chromosome 17q super-enhancer landscape in neuroblastoma

Long non-coding RNAs as upstream regulators and downstream effectors of TP53 activity in neuroblastoma

The chromosome 17q super-enhancer landscape in neuroblastoma

The HBP1 tumour suppressor at multiple regulatory cross roads in neuroblastoma

Synergistic combined molecular treatment targeting the HBP1 tumor suppressor gene in neuroblastoma

lncRNAs as upstream regulators and downstream effectors of TP53 in neuroblastoma

ETV5 functionally connect ALK and RET signaling in neuroblastoma

HBP1 downregulation through mutant ALK represents a novel mechanism for cooperative MYCN activation in neuroblastoma

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Contents

Support

Contact